Therapeutic management of ocular adnexal MALT lymphoma
- 22 May 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 8 (8), 1073-1083
- https://doi.org/10.1517/14656566.8.8.1073
Abstract
Non-Hodgkin lymphomas constitute 50% of all orbital malignancies. Mucosa-associated lymphoid tissue (MALT)-type lymphoma is the most common histology category in this anatomic region. Ocular adnexal lymphoma of MALT-type is an indolent and rarely lethal malignancy that can often be managed with observation alone. Occasionally, lymphomatous lesions determine the symptoms that condition a patient’s quality of life, and so require an immediate antineoplastic treatment. Several strategies are available, but reliable indications supported by prospective trials do not exist. Some therapeutic strategies are associated with substantial side effects and require a well-balanced therapeutic decision, which should take into account several variables related to the patient, the lymphoma, and the treatment itself. In this review, the authors analyze related literature and propose therapeutic guidelines for the management of ocular adnexal lymphoma of MALT-type.Keywords
This publication has 64 references indexed in Scilit:
- Ocular adnexal lymphoma: a review of clinicopathologic features and treatment optionsBlood, 2006
- Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patientsBritish Journal of Haematology, 2006
- Phase II Study of Oxaliplatin for Treatment of Patients With Mucosa-Associated Lymphoid Tissue LymphomaJournal of Clinical Oncology, 2005
- Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori TherapyJournal of Clinical Oncology, 2005
- Ophthalmologic and intraocular non‐Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factorsHematological Oncology, 2004
- Anti‐CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctivaEuropean Journal of Haematology, 2004
- Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical OutcomeJournal of Clinical Oncology, 2003
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT typeBlood, 2003
- Interferon treatment of childhood conjunctival lymphomaBritish Journal of Ophthalmology, 2003
- Radiotherapy is successful treatment for orbital lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 1993